These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 29527530)

  • 41. First report of the emergence of CTX-M-type extended-spectrum beta-lactamases (ESBLs) as the predominant ESBL isolated in a U.S. health care system.
    Lewis JS; Herrera M; Wickes B; Patterson JE; Jorgensen JH
    Antimicrob Agents Chemother; 2007 Nov; 51(11):4015-21. PubMed ID: 17724160
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A drug-resistant β-lactamase variant changes the conformation of its active-site proton shuttle to alter substrate specificity and inhibitor potency.
    Soeung V; Lu S; Hu L; Judge A; Sankaran B; Prasad BVV; Palzkill T
    J Biol Chem; 2020 Dec; 295(52):18239-18255. PubMed ID: 33109613
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antibiotic resistance and substrate profiles of the class A carbapenemase KPC-6.
    Lamoureaux TL; Frase H; Antunes NT; Vakulenko SB
    Antimicrob Agents Chemother; 2012 Nov; 56(11):6006-8. PubMed ID: 22908150
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Understanding the molecular determinants of substrate and inhibitor specificities in the Carbapenemase KPC-2: exploring the roles of Arg220 and Glu276.
    Papp-Wallace KM; Taracila MA; Smith KM; Xu Y; Bonomo RA
    Antimicrob Agents Chemother; 2012 Aug; 56(8):4428-38. PubMed ID: 22687511
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Allosteric communication in class A β-lactamases occurs via cooperative coupling of loop dynamics.
    Galdadas I; Qu S; Oliveira ASF; Olehnovics E; Mack AR; Mojica MF; Agarwal PK; Tooke CL; Gervasio FL; Spencer J; Bonomo RA; Mulholland AJ; Haider S
    Elife; 2021 Mar; 10():. PubMed ID: 33755013
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The role of residue 238 of TEM-1 beta-lactamase in the hydrolysis of extended-spectrum antibiotics.
    Cantu C; Palzkill T
    J Biol Chem; 1998 Oct; 273(41):26603-9. PubMed ID: 9756899
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Multidrug-resistant Klebsiella pneumoniae harboring extended spectrum β-lactamase encoding genes isolated from human septicemias.
    Carvalho I; Chenouf NS; Carvalho JA; Castro AP; Silva V; Capita R; Alonso-Calleja C; Enes Dapkevicius MLN; Igrejas G; Torres C; Poeta P
    PLoS One; 2021; 16(5):e0250525. PubMed ID: 33945553
    [TBL] [Abstract][Full Text] [Related]  

  • 48. β-lactamase-mediated resistance: a biochemical, epidemiological and genetic overview.
    Gutkind GO; Di Conza J; Power P; Radice M
    Curr Pharm Des; 2013; 19(2):164-208. PubMed ID: 22894615
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparative study of a novel plasmid-mediated beta-lactamase, CAZ-2, and the CTX-1 and CAZ-1 enzymes conferring resistance to broad-spectrum cephalosporins.
    Chanal CM; Sirot DL; Labia R; Petit A; Morand A; Sirot JL; Cluzel RA
    Antimicrob Agents Chemother; 1988 Nov; 32(11):1660-5. PubMed ID: 3075436
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Variants of β-lactamase KPC-2 that are resistant to inhibition by avibactam.
    Papp-Wallace KM; Winkler ML; Taracila MA; Bonomo RA
    Antimicrob Agents Chemother; 2015 Jul; 59(7):3710-7. PubMed ID: 25666153
    [TBL] [Abstract][Full Text] [Related]  

  • 51. TEM-4, a new plasmid-mediated beta-lactamase that hydrolyzes broad-spectrum cephalosporins in a clinical isolate of Escherichia coli.
    Paul GC; Gerbaud G; Bure A; Philippon AM; Pangon B; Courvalin P
    Antimicrob Agents Chemother; 1989 Nov; 33(11):1958-63. PubMed ID: 2692515
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Combination of Amino Acid Substitutions Leading to CTX-M-15-Mediated Resistance to the Ceftazidime-Avibactam Combination.
    Compain F; Dorchène D; Arthur M
    Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29941650
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Structures of ceftazidime and its transition-state analogue in complex with AmpC beta-lactamase: implications for resistance mutations and inhibitor design.
    Powers RA; Caselli E; Focia PJ; Prati F; Shoichet BK
    Biochemistry; 2001 Aug; 40(31):9207-14. PubMed ID: 11478888
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Genetic and structural insights into plasmid-mediated extended-spectrum β-lactamase activity of CTX-M and SHV variants among pathogenic Enterobacteriaceae infecting Indian patients.
    Dhara L; Tripathi A
    Int J Antimicrob Agents; 2014 Jun; 43(6):518-26. PubMed ID: 24794736
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Structure and dynamics of CTX-M enzymes reveal insights into substrate accommodation by extended-spectrum beta-lactamases.
    Delmas J; Chen Y; Prati F; Robin F; Shoichet BK; Bonnet R
    J Mol Biol; 2008 Jan; 375(1):192-201. PubMed ID: 17999931
    [TBL] [Abstract][Full Text] [Related]  

  • 56. KPC-2 β-lactamase enables carbapenem antibiotic resistance through fast deacylation of the covalent intermediate.
    Mehta SC; Furey IM; Pemberton OA; Boragine DM; Chen Y; Palzkill T
    J Biol Chem; 2021; 296():100155. PubMed ID: 33273017
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Chromosome-encoded extended-spectrum class A β-lactamase MIN-1 from Minibacterium massiliensis.
    Bercot B; Nordmann P; Drancourt M; Poirel L
    Antimicrob Agents Chemother; 2012 Jul; 56(7):4009-12. PubMed ID: 22526320
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evaluation of a DNA microarray, the check-points ESBL/KPC array, for rapid detection of TEM, SHV, and CTX-M extended-spectrum beta-lactamases and KPC carbapenemases.
    Naas T; Cuzon G; Truong H; Bernabeu S; Nordmann P
    Antimicrob Agents Chemother; 2010 Aug; 54(8):3086-92. PubMed ID: 20547813
    [TBL] [Abstract][Full Text] [Related]  

  • 59. High tolerance to simultaneous active-site mutations in TEM-1 beta-lactamase: Distinct mutational paths provide more generalized beta-lactam recognition.
    De Wals PY; Doucet N; Pelletier JN
    Protein Sci; 2009 Jan; 18(1):147-60. PubMed ID: 19177359
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Potency of Vaborbactam Is Less Affected than That of Avibactam in Strains Producing KPC-2 Mutations That Confer Resistance to Ceftazidime-Avibactam.
    Tsivkovski R; Lomovskaya O
    Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 32015028
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.